Trending...
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- New Mobile Car Detailing Platform Connects Drivers with On-Demand Local Pros
- Cal State LA secures funding for two artificial intelligence projects from CSU
SHANGHAI and SAN DIEGO, Nov. 7, 2024 ~ San Diego, California - WuXi XDC Cayman Inc. ("WuXi XDC"), a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in antibody-drug conjugates (ADCs) and other bioconjugates (XDCs), has been named the winner of the "Best CDMO" at the World ADC Awards 2024 for the second consecutive year. The company's consistent recognition at the World ADC Awards over the past three years, including being named the winner of "Best CDMO" in 2023 and "Best CMO Runner-up" in 2022, highlights its expertise and technical strength in driving innovation in the global ADC industry.
The prestigious award was presented at the World ADC San Diego conference, which brings together key industry experts, breakthrough technologies, and forward-thinking collaborations. The annual event recognizes outstanding achievements by teams, projects, technologies, and individuals in the global ADC industry. This year's conference highlighted the latest advancements in ADCs and XDCs from research through to commercialization.
Dr. Jimmy Li, CEO of WuXi XDC expressed his pride in winning this prestigious award for two consecutive years. He stated that it is a reflection of their team's relentless dedication to innovation and excellence. The recognition also underscores the significant trust their clients place in them as a global leader in the ADC industry.
More on The Californer
WuXi XDC's mission is to accelerate and transform the discovery, development, and manufacturing of bioconjugates through a comprehensive open-access platform. They aim to enable their global healthcare partners and benefit patients worldwide by providing state-of-the-art technologies and integrated solutions.
The company won the Best CDMO Winner award for its integrated one-stop CRDMO platform that significantly reduces timelines and mitigates risks associated with ADC development and manufacturing. With WuXi XDC's integrated solutions, they have shortened the DNA-to-IND timeline for ADCs to 15 months or less, cutting down the conventional timeline to enter clinical trials by almost half. Additionally, they accelerate the development to Biologics License Application (BLA) within 24-36 months.
WuXi XDC's success is attributed to their profound expertise in ADC technology, extensive experience in handling complex bioconjugates, and a truly integrated approach that unifies discovery, development, and manufacturing. By leveraging cutting-edge technologies and a global team of industry experts, WuXi XDC ensures seamless interdisciplinary collaboration, minimizing risks and maximizing efficiency throughout the ADC development process.
More on The Californer
Their all-in-one manufacturing strategy integrates all four key phases of ADC production - mAb intermediate, linker-payload, drug substance, drug product - into one single site. This approach ensures seamless coordination and the highest product quality, making WuXi XDC a reliable partner for clients seeking to advance their ADC/XDC programs efficiently and effectively. This combination of cutting-edge technology, industry experience, and integrated solutions distinguishes WuXi XDC as a leader in the evolving ADC landscape.
According to their 2024 interim report, WuXi XDC's leadership in the ADC field is demonstrated by its expanding client base of 419 clients globally. Notably, 13 of the top 20 global pharmaceutical companies (ranked by 2023 revenue) have chosen WuXi XDC as their trusted partner. This reflects the high level of confidence placed in the company's expertise and capabilities.
The recognition from the World ADC Awards highlights WuXi XDC's relentless pursuit of excellence in delivering comprehensive service solutions to global clients. As a leading CRDMO in ADC and bioconjugates, they strive to remain at the forefront of innovation and empower clients worldwide to accelerate the development of transformative therapies for patients worldwide.
The prestigious award was presented at the World ADC San Diego conference, which brings together key industry experts, breakthrough technologies, and forward-thinking collaborations. The annual event recognizes outstanding achievements by teams, projects, technologies, and individuals in the global ADC industry. This year's conference highlighted the latest advancements in ADCs and XDCs from research through to commercialization.
Dr. Jimmy Li, CEO of WuXi XDC expressed his pride in winning this prestigious award for two consecutive years. He stated that it is a reflection of their team's relentless dedication to innovation and excellence. The recognition also underscores the significant trust their clients place in them as a global leader in the ADC industry.
More on The Californer
- ICAST 2025: The Crystal-Clear Revolution Begins at Booth #3233
- Rachel Farris, CPA Featured on The AJ Brown Show to Discuss Act 60 Tax Incentives
- Brindle Pet Supplies Now Carries Badlands Ranch Dog Food in Canada
- Jade & Zelda Launch Virtually Human: A Groundbreaking Podcast Hosted by AI-Powered Virtual Humans
- Dr. Satyam Priyadarshy Joins Indemnify AI to Enrich AI Risk Financial Quantification
WuXi XDC's mission is to accelerate and transform the discovery, development, and manufacturing of bioconjugates through a comprehensive open-access platform. They aim to enable their global healthcare partners and benefit patients worldwide by providing state-of-the-art technologies and integrated solutions.
The company won the Best CDMO Winner award for its integrated one-stop CRDMO platform that significantly reduces timelines and mitigates risks associated with ADC development and manufacturing. With WuXi XDC's integrated solutions, they have shortened the DNA-to-IND timeline for ADCs to 15 months or less, cutting down the conventional timeline to enter clinical trials by almost half. Additionally, they accelerate the development to Biologics License Application (BLA) within 24-36 months.
WuXi XDC's success is attributed to their profound expertise in ADC technology, extensive experience in handling complex bioconjugates, and a truly integrated approach that unifies discovery, development, and manufacturing. By leveraging cutting-edge technologies and a global team of industry experts, WuXi XDC ensures seamless interdisciplinary collaboration, minimizing risks and maximizing efficiency throughout the ADC development process.
More on The Californer
- $10 Million Allocated to Establish Crypto Treasury Focused on High Value Ethereum (ETH) & Bitcoin (BTC) as Long-Term Holdings for Cybersecurity Leader
- Fact: Trump lied — again. California gas prices remain lower than a week ago, month ago, and a year ago
- Sing For Your Supper: A Night of Musical Comedy and Drag for a Great Cause
- Top "We Buy Houses" Companies in Oakland, CA Announced — JiT Home Buyers Leads the Pack in 2025
- Ansira Appoints Amalia Thomas As Chief Revenue Officer
Their all-in-one manufacturing strategy integrates all four key phases of ADC production - mAb intermediate, linker-payload, drug substance, drug product - into one single site. This approach ensures seamless coordination and the highest product quality, making WuXi XDC a reliable partner for clients seeking to advance their ADC/XDC programs efficiently and effectively. This combination of cutting-edge technology, industry experience, and integrated solutions distinguishes WuXi XDC as a leader in the evolving ADC landscape.
According to their 2024 interim report, WuXi XDC's leadership in the ADC field is demonstrated by its expanding client base of 419 clients globally. Notably, 13 of the top 20 global pharmaceutical companies (ranked by 2023 revenue) have chosen WuXi XDC as their trusted partner. This reflects the high level of confidence placed in the company's expertise and capabilities.
The recognition from the World ADC Awards highlights WuXi XDC's relentless pursuit of excellence in delivering comprehensive service solutions to global clients. As a leading CRDMO in ADC and bioconjugates, they strive to remain at the forefront of innovation and empower clients worldwide to accelerate the development of transformative therapies for patients worldwide.
Filed Under: Business
0 Comments
Latest on The Californer
- New AI platform helps small businesses deliver always-available, professional customer service without added staff or complexity
- VoiceGenie AI empowers small businesses with 24/7, brand-driven customer engagement through an AI-powered virtual front desk receptionist
- California: Governor Newsom signs tribal-state gaming compact 7.14.25
- VoiceGenie AI empowers small businesses with human-like call answering and customer engagement—bridging the gap between automation and live
- New 24/7 AI solution transforms customer engagement and efficiency for small businesses seeking live virtual receptionist services
- Next-generation virtual receptionist service leverages AI to ensure every customer call and text is answered, enhancing efficiency and engagem
- Next-Gen AI Receptionist Elevates Customer Communication, Boosts Efficiency for Small Businesses
- California: Governor Newsom signs legislation 7.14.25
- New AI-Powered Platform from Kell Web Solutions Delivers 24/7 Professional, Automated Call Handling and Appointment Scheduling
- Kell Web Solutions Launches Next-Gen VoiceGenie AI Call Answering Service for Businesses
- 24/7 Conversational AI Platform Raises the Standard for Small Business Customer Engagement
- Pyro Marketing Launches New Website to Accelerate Growth for Fitness Brands
- QuickLogic Announces the Passing of Board Director Christine Russell
- KCON LA 2025, 106.3 RAIN FM 'Take Over' Special Event
- IEI USA Launches SHIELD Rugged Stainless Steel Panel PCs for Hygiene-Critical Industries
- In historic first, California powered by two-thirds clean energy – becoming largest economy in the world to achieve milestone
- North Island Credit Union Foundation Provides $5,000 in Teacher Grants To Benefit Educators & Students
- The Citizens Commission on Human Rights Annual Purple Heart Day Event will be Hosted at the Historic Fort Harrison
- Blake Harris the Leading Authority in International Asset Protection Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- Wise Business Plans Emerges as a Go-To Partner for Angel Investors, VCs, Family Offices and Private